Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.7M Buy
12,635
+3,457
+38% +$4.74M 0.14% 127
2025
Q4
$9.82M Buy
9,178
+1,619
+21% +$1.69M 0.09% 194
2025
Q3
$7.32M Buy
7,559
+1,025
+16% +$806K 0.07% 235
2025
Q2
$5.24M Sell
6,534
-4,239
-39% -$3.04M 0.06% 266
2025
Q1
$7.14M Buy
10,773
+6,772
+169% +$4.93M 0.1% 182
2024
Q4
$2.77M Sell
4,001
-498
-11% -$358K 0.05% 342
2024
Q3
$3.75M Buy
4,499
+816
+22% +$730K 0.09% 220
2024
Q2
$3.77M Buy
3,683
+653
+22% +$628K 0.1% 198
2024
Q1
$2.94M Buy
3,030
+722
+31% +$640K 0.06% 297
2023
Q4
$1.75M Sell
2,308
-375
-14% -$248K 0.04% 405
2023
Q3
$1.58M Buy
+2,683
New +$1.78M 0.05% 372

Other funds holding ASML

Vident Advisory's ASML Position: Q1 2026 in Review

Vident Advisory increased its ASML (ASML) stake by 38% in Q1 2026, buying an estimated $4.74M and bringing the position to 12,635 shares worth $16.7M. The position accounts for 0.14% of the portfolio, ranked #127.

Vident Advisory first reported a position in ASML in Q3 2023 and has held it in 11 quarters since. 2,188 funds tracked by Wall St. Rank hold ASML as of Q1 2026.

  • Vident Advisory held 12,635 shares of ASML worth $16.7M as of Q1 2026.
  • Vident Advisory bought 3,457 ASML shares in Q1 2026, an estimated $4.74M.
  • ASML made up 0.14% of Vident Advisory's portfolio in Q1 2026, its #127 holding.
  • Vident Advisory first reported a position in ASML in Q3 2023 and has held it in 11 quarters since.
  • 2,188 funds tracked by Wall St. Rank held ASML as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.